Symptom profiles and palliative care in advanced pancreatic cancer - A prospective study

Supportive Care in Cancer

Volumn 14, Issue 11, 2006, Pages 1126-1133

  Labori, Knut Jørgen ^a   Hjermstad, Marianne Jensen ^a   Wester, Torunn ^a   Buanes, Trond ^a   Loge, Jon Håvard ^a  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

Author keywords

Edmonton Symptom Assessment Scale; Palliative care; Pancreatic cancer; Quality of life

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIEMETIC AGENT; ANXIOLYTIC AGENT; LAXATIVE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PANCREAS ENZYME; PARACETAMOL; SEDATIVE AGENT; STEROID;

ADULT; ADVANCED CANCER; AGED; ARTICLE; BYPASS SURGERY; CANCER PAIN; CANCER PALLIATIVE THERAPY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; PANCREAS CANCER; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE; SYMPTOMATOLOGY;

ADULT; AGED; AGED, 80 AND OVER; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NORWAY; PALLIATIVE CARE; PANCREATIC NEOPLASMS; PREVALENCE; PROSPECTIVE STUDIES; QUALITY OF LIFE; QUESTIONNAIRES; SEVERITY OF ILLNESS INDEX; SICKNESS IMPACT PROFILE; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 33749590358     PISSN: 09414355     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00520-006-0067-0     Document Type: Article

References (31)

1. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A et al (1993) The European Organization for Research and Treatment of Cancer: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365-376
2. Bachmann P, Marti-Massoud C, Blanc-Vincent MP, Desport JC et al (2003) Summary version of the standards, options and recommendations for palliative or terminal nutrition in adults with progressive cancer (2001). Br J Cancer 89(Suppl 1):S107-S110
3. Bruera E, Kuehn N, Miller MJ, Selmser P, Macmillan K (1991) The Edmonton Symptom Assessment System (ESAS): a simple method for the assessment of palliative care patients. J Palliat Care 7:6-9
4. Chow E, Wong R, Connolly R, Hruby G, Franssen E, Fung KW et al (2001) Prospective assessment of symptom palliation for patients attending a rapid response radiotherapy program: feasibility of telephone follow-up. J Pain Symptom Manage 22:649-656
5. Dormann A, Meisner S, Verin N, Wenk LA (2004) Self-expanding metal stents for gastroduodenal malignancies: systematic review of their clinical effectiveness. Endoscopy 36:543-550
6. Fayers PM, Aaronson N, Bjordal K, Groenvold M, Curran D, Bottomley A (2001) EORTC QLQ-C30 scoring manual (3rd edn). EORTC Quality of Life Group, Brussels, Belgium
7. Heedman PA, Strang P (2001) Symptom assessment in advanced palliative home care for cancer patients using the ESAS: clinical aspects. Anticancer Res 21:4077-4082
8. Fitzsimmons D, Johnson CD, George S, Payne S, Sandberg AA et al (1999) Development of a disease specific quality of life (QoL) questionnaire module to supplement the EORTC core cancer QoL questionnaire, the QLQ-C30 in patients with pancreatic cancer. EORTC Study Group on Quality of Life. Eur J Cancer 35:939-941
9. Hjermstad MJ, Fayers PM, Bjordal K, Kaasa S (1998) Health-related quality of life in the general Norwegian population assessed by the European Organization for Research and Treatment of Cancer core quality-of-life questionnaire: the QLQ=C30 (+3). J Clin Oncol 16:1188-1196
10. House MG, Choti MA (2004) Palliative therapy for pancreatic/biliary cancer. Surg Oncol Clin N Am 13:491-503,ix
11. Inui A (2002) Cancer anorexia-cachexia syndrome: current issues in research and management. CA Cancer J Clin 52:72-91
12. Jacox A, Carr DB, Payne R (1994) Management of cancer pain. Clinical practice guideline No. 9. AHCPR publication No. 94-0592. Rockville, MD. Agency for Health Care Policy and Research, U.S. Department of Health and Human Services, Public Health Service, March 1994, p. 19
13. Jemal A, Clegg LX, Ward E, Ries LA, Wu X, Jamison PM et al (2004) Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survival. Cancer 101(1):3-27
14. Jordhoy MS, Kaasa S, Fayers P, Ovreness T, Underland G et al (1999) Challenges in palliative care research; recruitment, attrition and compliance: experience from a randomized controlled trial. Palliat Med 13:299-310
15. Lillemoe KD, Cameron JL, Hardacre JM, Sohn TA, Sauter PK et al (1999) Is prophylactic gastrojejunostomy indicated for unresectable periampullary cancer? A prospective randomized trial. Ann Surg 230:322-328
16. Miaskowski C, Portenoy RK (1998) Update on the assessment and management of cancer-related fatigue. Princ Prac Support Oncol Updates 1(2):1-10
17. Morris JN, Sherwood S (1987) Quality of life of cancer patients at different stages in the disease trajectory. J Chronic Dis 40:545-556
18. Morris JN, Suissa S, Sherwood S, Wright SM, Greer D (1986) Last days: a study of the quality of life of terminally ill cancer patients. J Chronic Dis 39:47-62
19. Neoptolemos JP, Stocken DD, Friess H, Bassi C, Dunn JA, Hickey H et al (2004) A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med 350:1200-1210
20. Nieveen van Dijkum EJ, Kuhlmann KF, Terwee CB, Obertop H et al (2005) Quality of life after curative or palliative surgical treatment of pancreatic and periampullary carcinoma. Br J Surg 92:471-477
21. Osoba D, Rodrigues G, Myles J, Zee B, Pater J (1998) Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol 16:139-144
22. Rees E, Hardy J, Ling J, Broadley K, A'Hern R (1998) The use of the Edmonton Symptom Assessment Scale (ESAS) within a palliative care unit in the UK. Palliat Med 12:75-82
23. Schmier J, Elixhauser A, Halpern MT (1999) Health-related quality of life evaluations of gastric and pancreatic cancer. Hepatogastroenterology 46:1998-2004
24. Singh SM, Longmire WP Jr, Reber HA (1990) Surgical palliation for pancreatic cancer. The UCLA experience. Ann Surg 212:132-139
25. Sohn TA, Lillemoe KD, Cameron JL, Huang JJ, Pitt HA, Yeo CJ (1999) Surgical palliation of unresectable periampullary adenocarcinoma in the 1990s. J Am Coll Surg 188:658-666
26. Stone P, Richardson A, Ream E, Smith AG, Kerr DJ, Kearney N (2000) Cancer-related fatigue: inevitable, unimportant and untreatable? Results of a multi-centre patient survey. Cancer fatigue forum. Ann Oncol 11:971-975
27. van Geenen RC, van Gulik TM, Offerhaus GJ, de Wit LT, Busch OR et al (2001) Survival after pancreatico-duodenectomy for periampullary adenocarcinoma: an update. Eur J Surg Oncol 27:549-557
28. van Heek NT, De Castro SM, van Eijck CH, van Geenen RC et al (2003) The need for a prophylactic gastrojejunostomy for unresectable periampullary cancer: a prospective randomized multicenter trial with special focus on assessment of quality of life. Ann Surg 238:894-902
29. Ventafridda V, Tamburini M, Caraceni A, De Conno F, Naldi F (1987) A validation study of the WHO method for cancer pain relief. Cancer 59:850-856
30. Wong GY, Schroeder DR, Carns PE, Wilson JL, Martin DP et al (2004) Effect of neurolytic celiac plexus block on pain relief, quality of life, and survival in patients with unresectable pancreatic cancer: a randomized controlled trial. JAMA 291:1092-1099
31. Yeo CJ, Sohn TA, Cameron JL, Hruban RH, Lillemoe KD, Pitt HA (1998) Periampullary adenocarcinoma: analysis of 5-year survivors. Ann Surg 227:821-831